Acoustic Cavitation Lithotripsy
Low-pressure cavitation enhanced ultrasound. The world’s first system designed to enable an office based solution for kidney stone disease.
Avvio Medical aims to change the standard of care for the treatment of patients with urinary stone disease. Our novel office-based procedure enables shorter wait times without requiring fluoroscopy or general anesthesia, thereby reducing overall medical costs.
Our innovative technology employs low-pressure ultrasound to actuate calcium-seeking microbubbles, creating millions of micro-jets eroding the stone.*
Avvio Medical’s low-pressure ultrasound causes the Acoustic Enhancer microbubbles to expand and collapse, which helps break the ureteral stones.
What’s New
Applaud Medical Announces First Patient Enrolled in IDE Study
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced announced enrollment of the first patient in the company's prospective, multicenter, randomized, double-blind AEROLITH (Acoustic Enhancer Research on...
Applaud Medical Granted New U.S. Patent for the Company’s Acoustic Enhancer Techonology
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced that a new U.S. patent titled “Phospholipid compounds and formulations” (patent number 10,953,023) was granted to the company by the United States...
Applaud Medical Announces Announces Approval of Investigational Device Exemption (IDE) for Pivotal Study
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced it has received approval of an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to proceed with a pivotal study...